Dr. Chew is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Brookdale Dr
Lawrenceville, NJ 08648Phone+1 609-895-1127
Education & Training
- Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1980 - 1983
- Johns Hopkins UniversityResidency, Internal Medicine, 1977 - 1980
- Johns Hopkins University School of MedicineClass of 1977
Certifications & Licensure
- NJ State Medical License 1993 - 2025
- MD State Medical License 1979 - 1994
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Combined Phacotube vs Phacotrabeculectomy:A Randomized Controlled Trial Start of enrollment: 2005 Jul 01
- Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma Start of enrollment: 2006 Jul 01
- External Micropulse Diode Laser Transscleral Trabeculoplasty (EMDLT) for Severe Open Angle Glaucoma Start of enrollment: 2006 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 37 citationsThe Pravastatin Inflammation CRP Evaluation (PRINCE): Rationale and designMichelle A. Albert, Joan Staggers, Paul H. Chew, Paul M. Ridker
American Heart Journal. 2001-06-01 - 8 citationsCorrected TIMI frame count does not predict 30-day adverse outcomes after reperfusion therapy for acute myocardial infarction.Deepak L. Bhatt, Stephen G. Ellis, Thomas B. Ivanc, Tim Crowe, Eva Balazs
American Heart Journal. 1999-10-01 - 2 citationsRegional intracoronary analgesia during percutaneous transluminal coronary angioplasty.Thomas Aversano, Gary Walford, Mark G. Midei, Paul H. Chew, Sidney O. Gottlieb
Pain. 1993-01-01
Press Mentions
- Black Patient Inclusion in Clinical Trials Improves, but Asian, Latino and Other Groups 'Significantly' UnderrepresentedDecember 6th, 2021
- CorMedix Announces Publication of Taurolidine Pre-Clinical Oncology Data in Investigational New Drugs JournalJuly 8th, 2019
- CorMedix Inc. To Present at the 20th Annual Rodman & Renshaw Global Investment ConferenceApril 5th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: